ADIPOQ and polycystic ovary syndrome: Reports from our group showed that adiponectin signaling molecules are decreased in endometrial tissues from women with obesity and/or PCOS [9], which is also observed in cultured human endometrial cells treated with TNFα or with insulin plus testosterone, characteristic of obesity and PCOS, respectively [10].